To examine this more closely and characterize the number and location of SYNGR3+ cells, we performed multiplex IHC to examine SYNGR3 expression in T cells and more generally hematopoietic cells, as well as their distribution within different tumor compartments. This evidence concerns the gene SYNGR3 and neoplasm.